Now open for registration
Twenty years of clinical cancer genetic service –
from risk calculation to targeted therapies
Organising committee:
Ulf Kristoffersson, Håkan Olsson, Niklas Loman, Departments of Laboratory Medicine, and Clinical Sciences, Medical Faculty, Lund University, and Departments of Clinical Genetics and Oncology, University and Regional Laboratories, and Oncology, University Hospital, Region Skåne.
Venue: New Lecture Hall, Department of Oncology, Lund Date: September 20, 2013
Registration: www.dinkurs.se/oncogenetics Limited number of participants.
No show will be charged 500SEK
Contact/inquiries: Ulf.Kristoffersson@med.lu.se
Programme:
9.00 Welcome address Session 1.
09.15 Ulf Kristoffersson and Håkan Olsson, Lund: The Lund Oncogenetic clinic – achievements over 20 years
09.45 Paul Pharoah, Cambridge: “Genetic susceptibility to ovarian cancer: the story so far”
10.30 Break
Sesion 2
10.45 Anders Kvist, Lund: Massively parallel sequencing in clinical oncogenetics.
11.15 Susan Domcheck: Philadelphia "Benefits of BRCA1/2 testing: targeted screening, risk reduction and cancer therapy"
12.00 Hans Ehrencrona, Lund: Extended mutation studies in breast cancer, The SWEA study – what has been achieved after one year?
12.30 Lunch break
Sesion 3
13.30 Jukka-Pekka Mecklin, Tampere: “Screening and cancer prevention in Lynch syndrome”.
14.15 tba: Rare cancers – a challenge for the geneticist and the clinician
14.45 Break, tea and coffe
Sesion 4
15.15 Göran Jönsson, Lund: Melanoma - tumor biology and genetics" 15.45 Helena Jernström, Lund: Genes and lifestyle in breast cancer Sesion 5
16.15 General (panel) discussion: Where is oncogenetics heading? - important issues for the near future
17.00 End of day
